Cargando…

Onto better TRAILs for cancer treatment

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), also known as Apo-2 ligand (Apo2L), is a member of the TNF cytokine superfamily. By cross-linking TRAIL-Receptor (TRAIL-R) 1 or TRAIL-R2, also known as death receptors 4 and 5 (DR4 and DR5), TRAIL has the capability to induce apo...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Miguel, D, Lemke, J, Anel, A, Walczak, H, Martinez-Lostao, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832109/ https://www.ncbi.nlm.nih.gov/pubmed/26943322 http://dx.doi.org/10.1038/cdd.2015.174

Ejemplares similares

Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy
por: Naval, Javier, et al.
Publicado: (2019)

Lipid Nanoparticles Decorated with TNF-Related Aptosis-Inducing Ligand (TRAIL) Are More Cytotoxic than Soluble Recombinant TRAIL in Sarcoma
por: Gallego-Lleyda, Ana, et al.
Publicado: (2018)

DR5 Up-Regulation Induced by Dichloroacetate Sensitizes Tumor Cells to Lipid Nanoparticles Decorated with TRAIL
por: Marco-Brualla, Joaquín, et al.
Publicado: (2023)

Getting TRAIL back on track for cancer therapy
por: Lemke, J, et al.
Publicado: (2014)

Double-Edged Lipid Nanoparticles Combining Liposome-Bound TRAIL and Encapsulated Doxorubicin Showing an Extraordinary Synergistic Pro-Apoptotic Potential
por: De Miguel, Diego, et al.
Publicado: (2019)

Role of Exosomes in the Regulation of T-Cell Mediated Immune Responses and in Autoimmune Disease
por: Anel, Alberto, et al.
Publicado: (2019)

NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells
por: Ruggeri, P, et al.
Publicado: (2016)

On the TRAIL of Better Therapies: Understanding TNFRSF Structure-Function
por: Vanamee, Éva S., et al.
Publicado: (2020)

Harnessing TRAIL-induced cell death for cancer therapy: a long walk with thrilling discoveries
por: Montinaro, Antonella, et al.
Publicado: (2022)

Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1
por: Lemke, J, et al.
Publicado: (2014)

Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy
por: Kretz, Anna-Laura, et al.
Publicado: (2018)

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells
por: Tuthill, Mark H, et al.
Publicado: (2014)

TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
por: Mert, Ufuk, et al.
Publicado: (2019)

Bortezomib sensitises TRAIL-resistant HPV-positive head and neck cancer cells to TRAIL through a caspase-dependent, E6-independent mechanism
por: Bullenkamp, J, et al.
Publicado: (2014)

TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems
por: Alizadeh Zeinabad, Hojjat, et al.
Publicado: (2022)

An unexpected turn of fortune: targeting TRAIL-Rs in KRAS-driven cancer
por: von Karstedt, Silvia, et al.
Publicado: (2020)

Overcoming TRAIL Resistance for Glioblastoma Treatment
por: Deng, Longfei, et al.
Publicado: (2021)

Grafting TRAIL through Either Amino or Carboxylic Groups onto Maghemite Nanoparticles: Influence on Pro-Apoptotic Efficiency
por: Belkahla, Hanene, et al.
Publicado: (2021)

Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer
por: Shen, Xiao, et al.
Publicado: (2023)

Trailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer Cells
por: Trivedi, Rachana, et al.
Publicado: (2015)

Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family
por: Degli-Esposti, Mariapia A., et al.
Publicado: (1997)

Outdoor walking better? environmental elements of cardiorespiratory fitness training trails
por: Li, Ching, et al.
Publicado: (2023)

Splicing reprogramming of TRAIL/DISC-components sensitizes lung cancer cells to TRAIL-mediated apoptosis
por: Voss, Oliver H., et al.
Publicado: (2021)

The Role of TRAIL in Apoptosis and Immunosurveillance in Cancer
por: Pimentel, Julio M., et al.
Publicado: (2023)

MSC.sTRAIL Has Better Efficacy than MSC.FL-TRAIL and in Combination with AKTi Blocks Pro-Metastatic Cytokine Production in Prostate Cancer Cells
por: Mohr, Andrea, et al.
Publicado: (2019)

Behind the Adaptive and Resistance Mechanisms of Cancer Stem Cells to TRAIL
por: Quiroz-Reyes, Adriana G., et al.
Publicado: (2021)

TRAIL combinations: The new ‘trail’ for cancer therapy (Review)
por: REFAAT, ALAA, et al.
Publicado: (2014)

The Combination of TRAIL Treatment and Cancer Cell Selective Expression of TRAIL-Death Receptor DR4 Induces Cell Death in TRAIL-Resistant Cancer Cells
por: Choi, Eunah, et al.
Publicado: (2006)

The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells
por: Ryu, Sunhyo, et al.
Publicado: (2018)

Improving TRAIL-induced apoptosis in cancers by interfering with histone modifications
por: Zhang, Bao-Jie, et al.
Publicado: (2020)

A promising “TRAIL” of tanshinones for cancer therapy
por: Ho, Tsing-Fen, et al.
Publicado: (2015)

Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer
por: Stolfi, Carmine, et al.
Publicado: (2012)

Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy
por: Elmallah, Mohammed I. Y., et al.
Publicado: (2019)

Regulation of Cancer Metastasis by TRAIL/Death Receptor Signaling
por: Oh, You-Take, et al.
Publicado: (2021)

Nano-TRAIL: a promising path to cancer therapy
por: Gampa, Siri Chandana, et al.
Publicado: (2023)

Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2
por: Bertsch, U, et al.
Publicado: (2014)

The immune system on the TRAIL of Alzheimer’s disease
por: Burgaletto, Chiara, et al.
Publicado: (2020)

Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer
por: Norian, Lyse A., et al.
Publicado: (2011)

Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib
por: Lecis, D, et al.
Publicado: (2010)

Regulation of the human TRAIL gene
por: Allen, Joshua E., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6mdbh9ge9s61lg8m7cmmko4fi9